Literature DB >> 7017255

[Bone marrow transplantation for aplastic anaemia (author's transl)].

H J Kolb, G F Wündisch, I Spitzer, H Ochsler, L Stengel-Rutkowski, C Bender-Götze, E D Albert, H Sauer, G Ledderose, G Brehm, U Jehn, R Eckstein, W Mempel, W Wilmanns, R J Haas, M Helmig, B Netzel, B Belohradsky, G Janka, H Rodt, H Grosse-Wilde, E Thiel, H von Lieven, R Roloff, B L Krimmel, E Bunde, R Wank, D Schendel.   

Abstract

From March 1975 until May 1980 twelve patients with severe aplastic anemia were grafted with bone marrow from HLA-identical siblings by the Munich Cooperative Group for Bone Marrow Transplantation. Six patients are alive between 10 months and more than 5 years after grafting with normal blood values and marrow. One patient is treated as an out patient for chronic localized graft-versus-host disease (GvHD), five patients are well and without treatment. Six patients have died, one patient with a cerebral hemorrhage the day before transplantation, three patients following rejection of grafts 32, 40 and 55 days after grafting, one patient with severe GvHD 85 days after grafting and one patient, probably with interstitial pneumonia, following cerebral hemorrhage. Three of 6 patients who were conditioned with Cyclophosphamide (CY) only died following rejection of the graft. Two adults who were conditioned with CY and "total lymphoid irradiation" and three children, who wer given unirradiated leukocyte concentrates from the marrow donor after grafting, did not reject their grafts. The results of the Munich-Cooperative Group for Bone Marrow Transplantation are comparable to those of large, specialized centers for bone marrow transplantation, they indicate possibilities of cure of severe aplastic anemia by marrow grafts from HLA-identical siblings. They confirm that better results are obtained with earlier transplantation in the course of the disease.

Entities:  

Mesh:

Year:  1981        PMID: 7017255     DOI: 10.1007/bf01525001

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  52 in total

1.  [Course and prognosis of panmyelopathy and isolated aplastic anemia. Retrospective study in 70 patients].

Authors:  H Heimpel; C Rehbock; W van Eimeren
Journal:  Blut       Date:  1975-04

2.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

3.  Severe aplastic anaemia: a prospective study of the effect of androgens or transplantation on haematological recovery and survival.

Authors:  B M Camitta; E D Thomas
Journal:  Clin Haematol       Date:  1978-10

Review 4.  Prognostic factors in aplastic anaemia.

Authors:  D M Williams; R E Lynch; G E Cartwright
Journal:  Clin Haematol       Date:  1978-10

5.  GVHD suppression by incubation of bone marrow grafts with anti-T-cell globulin: effect in the canine model and application to clinical bone marrow transplantation.

Authors:  H Rodt; H J Kolb; B Netzel; I Rieder; G Janka; B Belohradsky; R J Haas; S Thierfelder
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

6.  Marrow transplanation in man following cyclophosphamide.

Authors:  G W Santos; L L Sensenbrenner; P J Burke; M Colvin; A H Owens; W B Bias; R E Slavin
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

7.  Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts.

Authors:  R Storb; R B Epstein; T C Graham; E D Thomas
Journal:  Transplantation       Date:  1970-03       Impact factor: 4.939

8.  The cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype Sl-Sld.

Authors:  E A McCulloch; L Siminovitch; J E Till; E S Russell; S E Bernstein
Journal:  Blood       Date:  1965-10       Impact factor: 22.113

9.  Bolus methylprednisolone in severe aplastic anemia.

Authors:  A Bacigalupo; D Giordano; M T Van Lint; R Vimercati; A M Marmont
Journal:  N Engl J Med       Date:  1979-03-01       Impact factor: 91.245

10.  Bone-marrow microenvironment defect in congenital hypoplastic anemia.

Authors:  W B Ershler; J Ross; J L Finlay; N T Shahidi
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

View more
  1 in total

1.  Remission induction in a patient with severe aplastic anemia and renal failure by immunosuppressive treatment including antithymocyte globulin.

Authors:  H G Hartmann; H W Pees; G A Jutzler; P G Scheurlen
Journal:  Blut       Date:  1982-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.